Becton Dickinson India
VC Fund
Gurgaon, India
Becton Dickinson India is a VC fund in Gurgaon focused on Health Care and Medical. BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 64%
Last updated:
For AI agents: llms.txt
Industries Becton Dickinson India invests in
Stages Becton Dickinson India invests in
Countries Becton Dickinson India invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ahmed Saleh
|
|||
Antoine (Tony) Ezell
|
|||
Carlos Gomez
|
|||
Christopher DelOrefice
|
|||
Dana-Megan Rossi
|
|||
| See all 9 contacts → | |||
Investment Focus
Industry
- Health Care 9 (82%)
- Medical 4 (36%)
- Biotechnology 3 (27%)
- Medical Device 3 (27%)
- Hospital 2 (18%)
Stage
- Grant 5 (45%)
- Seed 1 (9%)
- Series B 1 (9%)
- Corporate Round 1 (9%)
- Post-IPO Equity 1 (9%)
Country
- United States 9 (82%)
- Israel 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ahmed Saleh
Clinical Program Manager, Global Clinical Affairs
|
Clinical Program Manager, Global Clinical Affairs | Total investments: 0 | Find email | |
|
Antoine (Tony) Ezell
Executive Vice President, Chief Marketing Officer
|
Executive Vice President, Chief Marketing Officer | Total investments: 0 | Find email | |
|
Carlos Gomez
Senior Internal Auditor
|
Senior Internal Auditor | Total investments: 0 | Find email | |
|
Christopher DelOrefice
EVP & CFO
|
EVP & CFO | Total investments: 0 | Find email | |
|
Dana-Megan Rossi
Director of Cybersecurity Regions
|
Director of Cybersecurity Regions | Total investments: 0 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Babson Diagnostics
|
Babson Diagnostics is an operator of a healthcare technology company dedicated to bringing diagnostic blood testing to the retail pharmacy counter. The company develops a model for the blood test that requires only one-tenth of the sample size of traditional venipuncture methods, that enable consumers to get laboratory-grade bloodwork done within ashort wait time. | Corporate Round / Oct 08, 2024 | |
Kanso Diagnostics
|
Kanso Diagnostics is a molecular testing platform for diagnosis of bacterial and viral infections. | Seed / Sep 01, 2024 | |
Valley Health System
|
Valley Health System is a regional healthcare system that serves residents in northern New Jersey and southern New York. It is comprised of The Valley Hospital, Valley Home Care, and Valley Medical Group. Its services include cardiology, oncology, women’s and children’s services, emergency care, orthopedics, and neurosciences. Through itscomprehensive inpatient and outpatient programs, highly skilled home care services, community-based medical practices, and wellness programs, and collaborations with some of the world's leading healthcare organizations, it is dedicated to keeping communities healthy. | $652K / Grant / Nov 03, 2022 | |
Wahiawā Center for Community Health
|
Wahiawā Health provides access to affordable, quality health care and wellness services to promote a healthy community. | $270K / Grant / Aug 08, 2022 | |
Share Ourselves
|
Share Ourselves offers personalized care as a means to deliver quality services, improve population health and stability, and reduce costs. They also provides pediatric care, women's health, behavioral health, clinical pharmaceutical services, food pantry, financial assistance, homeless services, health education, case management, and an OBprogram. | $270K / Grant / Aug 08, 2022 | |
HealthNet
|
HealthNet provides high-quality medical, dental, behavioral health care and support services to people of all age, regardless of insurance. | $270K / Grant / Aug 08, 2022 | |
Northeast Valley Health
|
Northeast valley health corporation (NEVHC) is one of the nation's community health centers. They are a nonprofit organization, focused on preventing and alleviating health issues. While their patients are united by their experience of medical need, they come from every walk of life and background. The mission of northeast valley healthcorporation is to provide, safe and comprehensive healthcare to the medically underserved residents of los angeles county, particularly in the san fernando and santa clarita valleys, in a manner that is sensitive to the economic, social, cultural, and linguistic needs of the community. | $270K / Grant / Aug 08, 2022 | |
Day Zero Diagnostics
|
The future of infectious disease diagnostics starts at Day Zero. By using whole-genome sequencing (WGS) and our proprietary enabling technologies, Day Zero is creating a new class of sequencing-based in-vitro diagnostics that generates clinically actionable data at scale. Our technologies include novel sample preparation methods enablingunprecedented ultra-high enrichment of pathogen DNA for sequencing directly from clinical samples, machine learning algorithms that provide clinically actionable diagnostic results, and a world-class database of WGS and drug efficacy profiles. Day Zero Diagnostics is on a mission to transform the way infectious disease diagnostics are performed by generating the stream of real-time sequencing data required to change how we track, manage and combat infectious diseases.With an enormous unmet clinical and economic need, we are targeting bloodstream infections and sepsis for our first application. The life expectancy of a patient with septic shock is 24 hours without fast effective antibiotic treatment. However, even when successful, current diagnostics take 2-5 days to identify the pathogen AND provide its antibiotic susceptibility profile. The lack of rapid, accurate, and comprehensive diagnostics, forces physicians to “carpet bomb” patients with severe infections with powerful, yet toxic, broad-spectrum antibiotics, which is not only ineffective in many cases but can also lead to significant morbidity and mortality. Day Zero delivers a complete diagnosis, including both the species and antibiotic resistance profile, in hours vs. days, enabling the physician to use a targeted treatment on day zero of hospital admission and resulting in better patient outcomes and cost savings. | $21M / Venture - Series Unknown / Feb 09, 2022 | |
Vicarious Surgical
|
Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goal of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs. | $142M / Post-IPO Equity / Sep 20, 2021 | |
|
HealthNet
|
HealthNet provides high-quality medical, dental, behavioral health care and support services to people of all age, regardless of insurance. | $150K / Grant / Aug 10, 2021 | |
| See all 11 investments → | |||
Co-Investors
Direct Relief
4 deals together
National Association of Community Health Centers
4 deals together
Bristol-Myers Squibb
1 deal together
E15 VC
1 deal together
Golden Seeds
1 deal together
Hongkou Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Becton Dickinson India invest in?
Becton Dickinson India invests primarily in Health Care, Medical and Biotechnology startups, most often at Grant and Seed stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Becton Dickinson India?
Public channels for Becton Dickinson India include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Becton Dickinson India?
The team at Becton Dickinson India includes Ahmed Saleh (Clinical Program Manager, Global Clinical Affairs), Antoine (Tony) Ezell (Executive Vice President, Chief Marketing Officer) and Carlos Gomez (Senior Internal Auditor), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
